Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Lifelike Biomatic develops new drugs that act on a combination of multiple known targets of disease mechanisms, and could lead to new therapies for cognitive disorders such as Alzheimer’s disease. Our scientists have shown that drugs which act on multiple targets have higher efficacy at lower doses, resulting in an improved safety-efficacy profile. Our discovery approach is driven by a patented simulation-based platform that integrates the complex network of targets of disease mechanisms and identifies optimal patterns of synergistic physiological activities. ( www.lifelikebiomatic.com )
Lifelike Biomatic Inc
2501 Wildwood Way
Roanoke, Texas 75262
USA
Tel: (817) 253-4129